Navigation Links
New Study Finds Pharmacists and Nurses are the Most Effective Health Care 'Voices' in Promoting Medication Adherence
Date:12/22/2010

WOONSOCKET, R.I., Dec. 22, 2010 /PRNewswire/ -- A new study looking at in-person, electronic, telephonic, fax and mail communications that counsel patients to stay on their medications concludes that pharmacists at a retail store are the most influential health care "voice" in getting patients to take medicine as prescribed.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

The research, based on a review of more than 40 years of studies published in medical journals, showed that nurses talking with patients as they are discharged from a hospital are the second most influential voice encouraging patients to stay on their medicines. Both in-store pharmacists and hospital-based nurses are more effective than pharmacists communicating to a patient via the telephone or doctors instructing patients regarding prescriptions, the researchers said.

These findings are contained in two separate reviews of medical journal studies sponsored by CVS Caremark and carried out by a team of researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark. This week the American Journal of Managed Care (AJMC) published a review that focused on communications between pharmacists and nurses with their patients. The AJMC study builds upon a review by the same researchers that focused on doctor and patient communications and was published last May in the Journal of General Internal Medicine.

"There have been many studies on the subject of boosting adherence. We decided it was important to review the total body of work to determine which communication channel had the greatest impact," said William Shrank, MD, MSHS, of Brigham and Women's Hospital and Harvard, and a lead author of the studies. Shrank said the researchers combed through more than 6,500 medical journal articles published between 1966 and December 31, 2008, before reviewing 168 articles in full.  

The study found that programs using mail, fax and brochure-type (non-personal) communications had relatively low impact on promoting patient adherence. A review of the use of electronic communications, such as videos and interactive technology, show promise but were determined to have medium impact on increasing adherence among patients.

The highest impact programs featured work by pharmacists talking to patients in a store, followed by nurses talking face-to-face with patients who were leaving a hospital, the researchers concluded. Face-to-face discussions between pharmacists and patients in a store were twice as effective boosting adherence rates as programs where pharmacists talk with patients on the telephone, the researchers found.  

"These findings offer payers, health care providers and policy makers guidance about how to develop programs that improve patient adherence," said Troyen A. Brennan, MD, MPH, executive vice president and chief medical officer of CVS Caremark, and an author of both reviews. "We know that pharmacists and nurses are among the most trusted health care professionals. This study shows that trust translates into effective patient communications."

Improving adherence is important because by keeping patients on prescriptions as directed their health status is stabilized.  Further, medication adherence is a cost-effective way to avoid unnecessary doctors' visits or hospitalizations. Non-adherence to medications cost s the health care system up to $290 billion a year because many of the hospitalizations can be avoided if people take prescriptions as doctors direct.

The study is a product of CVS Caremark's previously announced three-year collaboration with Harvard University and Brigham and Women's Hospital to research pharmacy claims data to better understand patient behavior, particularly around medication adherence.

About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access, to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including approximately 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com.Media Contact:Jon SandbergCVS Caremark(401)770 4914jlsandberg@cvs.com
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Market Study Gives Thumbs Up for Pepex™ Trio™ One-Click™ Blood Glucose Meter
2. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
3. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
4. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
5. Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer
6. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
7. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study
8. Study Shows BSGI/MBI Contributes Significantly to Patient Management with Its Ability to Detect Breast Cancer in Difficult to Diagnose Patients
9. ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
10. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
11. Published Study Concludes: Vented Baby Bottles Protect Essential Nutrients in Breast Milk and Formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... SAN DIEGO , Dec. 9, 2016 /PRNewswire/ ... with Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ... program targeting ,LpxC, for the treatment of bacterial ... LpxC has been recognized as an attractive antibacterial ... however, a lack of suitable chemical starting points ...
(Date:12/8/2016)... , Dec. 8, 2016  The global biosurgery ... 8.8% during the forecast period of 2016 to 2021. ... by 2021 from USD 18.21 billion in 2016. The ... rising incidences of sports related injuries and spinal problems, ... rising need of effective blood loss management. ...
(Date:12/8/2016)... , Dec. 8, 2016 Allergy ... includes products and tests that are used to ... weed, peanuts, milk, or drugs etc. in the ... by the immune system. The report on global ... prospects of the market. The report consists of ...
Breaking Medicine Technology:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... An ... permit amputees to safely ride all types of amusement park rides. , The patent-pending ... the unit is easy to use and could be set up in a matter ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pennsylvania Cable Network (PCN) during the summer of 2016. The program was made ... by the United States Department of Health and Human Services Administration. The ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate that ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
Breaking Medicine News(10 mins):